Indication
Invasive Aspergillosis
7 clinical trials
8 products
Clinical trial
A Phase 2, Open-Label, Non-Comparative, Multicenter Study to Evaluate the Safety and Tolerability, Efficacy and Pharmacokinetics of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric SubjectsStatus: Completed, Estimated PCD: 2022-12-14
Product
IsavuconazoniumProduct
PosaconazoleClinical trial
A Phase 2, Open-Label, Non-Comparative Clinical Trial to Study the Safety and Efficacy of Posaconazole (POS, MK-5592) in Pediatric Participants Aged 2 to Less Than 18 Years With Invasive AspergillosisStatus: Completed, Estimated PCD: 2023-12-18
Clinical trial
Patterns of Real-World Isavuconazole Use, Effectiveness, Safety, and Healthcare Resource Utilization-a Retrospective Chart Review Study of Patients With Mucormycosis or Invasive Aspergillosis (PRISMA)Status: Completed, Estimated PCD: 2023-12-23
Product
IsavuconazoleProduct
OlorofimClinical trial
Phase III, Adjudicator-blinded, Randomised Study to Evaluate Efficacy and Safety of Treatment With Olorofim Versus Treatment With AmBisome® Followed by Standard of Care in Patients With Invasive Fungal Disease Caused by Aspergillus SpeciesStatus: Recruiting, Estimated PCD: 2024-09-14
Product
AmBisome®Clinical trial
An Open Clinical Trial to Evaluate the Safety, Efficacy and Population Pharmacokinetics of Amphotericin B Cholesteryl Sulfate Complex for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusStatus: Not yet recruiting, Estimated PCD: 2025-08-15
Clinical trial
Azole-echinocandin Combination Therapy for Invasive Aspergillosis A Randomized Pragmatic Superiority TrialStatus: Terminated, Estimated PCD: 2024-05-01
Product
AzoleProduct
AnidulafunginClinical trial
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal InfectionStatus: Recruiting, Estimated PCD: 2023-12-30